Stock A131030 OPTUS PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company OPTUS Pharmaceutical Co., Ltd.

Equities

A131030

KR7131030009

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-05-02 EDT 		5-day change 1st Jan Change
6,310 KRW -0.63% Intraday chart for OPTUS Pharmaceutical Co., Ltd. +2.77% +18.61%
2023 OPTUS Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
2022 Tranche Update on OPTUS Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 7, 2022. CI

Business Summary

Optus Pharmaceutical Co Ltd, formerly DHP Korea Co Ltd, is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company is primarily engaged in the manufacture and sale of eye drops and ophthalmic preparations such as dry eye treatment agents, conjunctivitis treatment agents, anti-inflammatory medication agents, glaucoma treatment agents and others.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Product
99.2 %
58,321 99.4 % 71,868 99.2 % +23.23%
Other
0.5 %
336 0.6 % 356 0.5 % +5.84%
Merchandise
0.3 %
- - 203 0.3 % -

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
99.1 %
58,052 99.0 % 71,740 99.1 % +23.58%
Overseas
0.9 %
606 1.0 % 686 0.9 % +13.30%

Managers

Managers TitleAgeSince
Eun-Young Park CEO
 Chief Executive Officer 49 -
Sang-Hak Choi CTO
 Chief Tech/Sci/R&D Officer 56 -
Young-Woon Park BRD
 Director/Board Member 58 -
Tae-Eun Jang BRD
 Director/Board Member 62 13-10-09
Hye-Jo Choi PRN
 Corporate Officer/Principal 61 -
Dae-Han Kim AUD
 Comptroller/Controller/Auditor 68 13-10-09

Members of the board

Members of the board TitleAgeSince
Woo-Seok Koh BRD
 Director/Board Member 65 -
Tae-Eun Jang BRD
 Director/Board Member 62 13-10-09
Young-Woon Park BRD
 Director/Board Member 58 -
Eun-Young Park CEO
 Chief Executive Officer 49 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 16,153,162 8,772,603 ( 54.31 %) 893,920 ( 5.534 %) 54.31 %

Shareholders

NameEquities%Valuation
SAM CHUN DANG PHARM. CO., LTD
39.36 %
6,357,733 39.36 % 33 M ₩
OPTUS PHARMACEUTICAL CO., LTD.
6.112 %
987,214 6.112 % 5 M ₩
Dimensional Fund Advisors Ltd.
0.0518 %
8,362 0.0518 % 43 666 ₩
DFA Australia Ltd.
0.001907 %
308 0.001907 % 1 608 ₩

Holdings

NameEquities%Valuation
OPTUS PHARMACEUTICAL CO., LTD.
6.11%
 987,214 6.11% 5,155,143 $

Company contact information

OPTUS Pharmaceutical Co., Ltd.

50 Osongsaengmyeong 6-ro Osong-eup

28158, Cheongju-si

+

http://www.optuspharm.com
address OPTUS Pharmaceutical Co., Ltd.(A131030)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals

Sales per Business

Sales per region

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
OPTUS PHARMACEUTICAL CO., LTD. Stock OPTUS Pharmaceutical Co., Ltd.
+18.61% 75.24M
MERCK KGAA Stock Merck KGaA
+5.48% 71.19B
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+12.55% 9.3B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-13.75% 5.01B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+42.38% 4.47B
YUHAN CORPORATION Stock Yuhan Corporation
+4.51% 3.96B
INDIVIOR PLC Stock Indivior PLC
+21.10% 2.44B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-19.05% 2.41B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-28.72% 2.23B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+11.13% 2.02B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A131030 Stock
  4. Company OPTUS Pharmaceutical Co., Ltd.